# Patient Profile: Louise Stoten

## Personal Information
- **Full Name:** Louise Jane Stoten
- **Date of Birth:** 08/04/1969
- **Date of Death:** September 16, 2025
- **Age at Death:** 56 years
- **Mobile:** 078 275 9753
- **Email:** stoten8qt@btinternet.com
- **Billing Address:** 3 Hill Street, Plettenberg Bay, 6600 (South Africa)
- **Malta Address:** Apt 30, 60 Ghar U Casa, IL Mellieha, Malta MLH5132
- **Occupation:** Tax Lawyer (earning ~Â£250,000/year per husband)
- **Sanctura Account No:** STO1

## Medical History

### Cancer History
- **2010:** First diagnosed with right-sided breast cancer
  - Operated on by Gerald Gui
  - Surgery and radiation therapy
  - Did NOT have endocrine therapy (due to Factor V Leiden deficiency)

- **2015:** Mastectomy due to radiation scarring

- **2019:** Diagnosed with metastatic disease
  - Presented with right-sided Horner's syndrome
  - Neck and shoulder pains
  - Has since received treatment in South Africa, Turkey, and elsewhere

### Primary Diagnosis
- **Condition:** Stage IV Metastatic Breast Cancer
- **ICD-10 Code:** C50.9
- **Metastases:** Lung, liver, and skeletal (including T7 compression fracture)

### Receptor Status & Mutations
| Marker | Status |
|--------|--------|
| HER2 | Low positive (score 0) |
| Estrogen Receptor (ER) | 100% positive |
| Progesterone Receptor (PR) | 100% positive |
| ESR1 Mutation | Present |
| PIK3CA Mutation | Present |

### Other Medical History
- Fibroids
- Factor V Leiden deficiency (contraindication for endocrine therapy)
- Titanium rod in right femur (placed prior to leaving South Africa)
- Port on chest

### Family History
- Maternal grandmother: Breast cancer in her 70s

### Lifestyle
- Non-smoker
- Minimal alcohol consumption

## Prognosis
Per Prof. Justin Stebbing's letter dated July 10, 2025:
> "I confirm that Louise's prognosis is likely to be less than 12 months."

## Previous Oncology Treatments
1. Gemcitabine
2. Capecitabine
3. Epirubicin
4. Paclitaxel (Taxol) - showed good disease control
5. Bevacizumab (Avastin) - discontinued 6 weeks before July 2025
6. Ribociclib + Letrozole - started prior to July 2025
7. Zoledronic Acid
8. Photodynamic Therapy
9. Various integrative treatments (South Africa, Turkey, elsewhere)
